SCHEMBL5058376

SCHEMBL5058376

COc1ccc(N)c(CCc2cc(OC)ccc2N)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.55
CYP3A4 P08684 3/20 0.55
ADRA1A P35348 1/20 0.53
TAAR1 Q96RJ0 1/20 0.53
MEN1 O00255 2/20 0.50
MAPT P10636 2/20 0.50
THRB P10828 2/20 0.50
KMT2A Q03164 2/20 0.50
IDO1 P14902 2/20 0.48
TDP1 Q9NUW8 3/20 0.48
KDM4E B2RXH2 1/20 0.48
GAA P10253 1/20 0.48
RECQL P46063 1/20 0.48
BLM P54132 1/20 0.48
MCL1 Q07820 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
AOC3 Q16853 1/20 0.47
HTR2A P28223 1/20 0.46
MAPK1 P28482 1/20 0.44
BACE1 P56817 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2019106 0.90 TAAR1 (0.68) ALDH1A1CYP3A4ADRA1ATAAR1MEN1
SCHEMBL27848999 0.88 ALDH1A1 (0.48) ALDH1A1CYP3A4ADRA1ATAAR1MEN1
SCHEMBL19783801 0.88 CYP2D6 (0.51) ALDH1A1CYP3A4ADRA1ATAAR1MEN1
SCHEMBL30189619 0.88 CYP2D6 (0.51) ALDH1A1CYP3A4ADRA1ATAAR1MEN1
SCHEMBL8680435 0.87 ALDH1A1 (0.47) ALDH1A1CYP3A4ADRA1ATAAR1MEN1
SCHEMBL774393 0.85 ALDH1A1 (0.53) ALDH1A1CYP3A4ADRA1ATAAR1MEN1
SCHEMBL1911809 0.85 ALDH1A1 (0.53) ALDH1A1CYP3A4ADRA1ATAAR1MEN1
SCHEMBL7771779 0.84 HTR2A (0.45) ALDH1A1CYP3A4ADRA1ATAAR1MEN1
SCHEMBL774392 0.83 ALDH1A1 (0.57) ALDH1A1CYP3A4ADRA1ATAAR1MEN1
SCHEMBL3377786 0.83 ALDH1A1 (0.52) ALDH1A1CYP3A4ADRA1ATAAR1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7354928-B2 Small molecule inhibitors targeted at Bcl-2 THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2008-04-08 US disclosed
US-7354928-B2 Small molecule inhibitors targeted at Bcl-2 THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2008-04-08 US disclosed
US-7354928-B2 Small molecule inhibitors targeted at Bcl-2 THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2008-04-08 US disclosed
US-20080058322-A1 Small molecule inhibitors targeted at Bcl-2 THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2008-03-06 US disclosed
US-20080058322-A1 Small molecule inhibitors targeted at Bcl-2 THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2008-03-06 US disclosed
US-20080058322-A1 Small molecule inhibitors targeted at Bcl-2 THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2008-03-06 US disclosed
US-20030199489-A1 Small molecule inhibitors targeted at BCL-2 THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2003-10-23 US disclosed
WO-2003038060-A2 SMALL MOLECULE INHIBITORS TARGETED AT BCL-2 THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2003-05-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058322-A1 Small molecule inhibitors targeted at Bcl-2 BCL2, BCL2L1, BCL2L2 ALDH1A1 4519/4885CYP3A4 4786/4885ADRA1A 4832/4885
US-20030199489-A1 Small molecule inhibitors targeted at BCL-2 BCL2L1, BCL2, BCL2L2 ALDH1A1 4435/4885CYP3A4 4808/4885ADRA1A 4815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.